Effects of Jingyuankang Capsules (精元康胶囊) on Leukocyte Level in AIDS Patients

Objective: To observe the therapeutic effects of Jingyuankang capsules (精元康胶囊) for leukopenia in AIDS patients. Methods: In this randomized double-blind trial, 58 patients orally took Jingyuankang capsule, analog Leucogen tablet and the HAART (highly active anti-retroviral therapy) drugs, and the ot...

Full description

Saved in:
Bibliographic Details
Published inJournal of traditional Chinese medicine Vol. 31; no. 1; pp. 32 - 35
Main Author 蒋士卿 孙宏新 徐英敏 蒋艳玲 裴俊文 王红玲
Format Journal Article
LanguageEnglish
Published 2011
Subjects
Online AccessGet full text
ISSN0255-2922

Cover

More Information
Summary:Objective: To observe the therapeutic effects of Jingyuankang capsules (精元康胶囊) for leukopenia in AIDS patients. Methods: In this randomized double-blind trial, 58 patients orally took Jingyuankang capsule, analog Leucogen tablet and the HAART (highly active anti-retroviral therapy) drugs, and the other 58 patients took Leucogen tablet, analog Jingyuankang capsule and the HAART drugs all for 6 months, during which the peripheral hemogram was periodically examined to observe the therapeutic effects of Jingyuankang capsule for leukopenia of the AIDS patients. Results: With good therapeutic effect for leukopenia of the AIDS patients, Jingyuankang capsule can enhance leukocyte level as effective as Leucogen tablet in treating grade Ⅰ and grade Ⅱ leukopenia, and more effectively than Leucogen tablet in treating grade Ⅲ leukopenia. No toxic side-effects and adverse reactions were found during the treatment and in the follow-up visit. Conclusion: Jingyuankang capsule can effectively treat leukopenia of the AIDS patients.
Bibliography:TQ336.15
S881.2
clinical research
Jingyuankang Capsules, HIV/AIDS
11-2167/R
Jingyuankang Capsules, HIV/AIDS; HAART therapy, TCM therapy, leukopenia; clinical research
HAART therapy, TCM therapy, leukopenia
ISSN:0255-2922